Publication | Closed Access
Abstract 11395: Small Molecule Antidote for Anticoagulants
43
Citations
0
References
2012
Year
ThrombosisDrug InteractionsMolecular PharmacologyMedicineSignificant AdvantagesAnticoagulantPharmacotherapyIia InhibitorsDrug DevelopmentPharmacologySmall Molecule AntidoteHeparinsDrug DiscoveryAntithrombotic Agents
New generation oral factor Xa and IIa inhibitors offer significant advantages over heparins and warfarin with regards to route of administration, drug interactions and predictability of bioactivity...